n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with dihydroceramide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiraishi, H; Shimada, T; Terano, A | 1 |
1 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and dihydroceramide
| Article | Year |
|---|---|
Hepatocyte growth factor protects gastric epithelial cells against ceramide-induced apoptosis through induction of cyclooxygenase-2.
Topics: Animals; Apoptosis; Cell Line; Cell Survival; Ceramides; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Induction; Gastric Mucosa; Hepatocyte Growth Factor; Humans; In Situ Nick-End Labeling; Isoenzymes; Membrane Proteins; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Rats; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sphingosine; Sulfonamides; Transcription, Genetic | 2000 |